COLORADO SPRINGS, Colo., Dec. 27, 2012 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that it will be presenting at the 31st Annual J.P. Morgan Healthcare Conference being held January 7 – 10, 2013 in San Francisco. Scott Drake, Spectranetics' Chief Executive Office and Guy Childs, Chief Financial Officer, are scheduled to speak at 10:30 a.m. Pacific time on Thursday, January 10 th. Interested parties can access a live audio webcast at www.spectranetics.com. An archived presentation will be available on the Web site for 30 days. Scott Drake and Guy Childs will also be hosting investor meetings throughout the conference. About Spectranetics Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in more than 40 countries and are used to treat arterial blockages in the heart and legs, as well as the removal of pacemaker and defibrillator leads. The Company's Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages. The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads. For more information, visit www.spectranetics.com.
CONTACT: COMPANY CONTACT The Spectranetics Corporation Guy Childs, Chief Financial Officer (719) 633-8333 INVESTOR CONTACTS Westwicke Partners Lynn Pieper or Nicole Hellendoorn (415) 202-5678 firstname.lastname@example.org